Pieris Pharma (PIRS) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Pieris Pharma (PIRS) Tops Q2 EPS by 2c

Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2015

August 12, 2015 5:51 PM EDT

FREISING, GERMANY -- (Marketwired) -- 08/12/15 -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® biotherapeutic technologies, today reported financial results for the second quarter of 2015, and provided an update on the Company's recent developments.

"Over the past six months, Pieris has made significant progress across the board," said Stephen Yoder, President and CEO. "In July we closed a public offering of our common... More